Related Articles
Keratinocyte injury in drug-induced toxic epidermal necrolysis: Simultaneous but distinct topographic expression of CD95R and calprotectin
Differential pathomechanisms of epidermal necrolytic blistering diseases
Purulent bullous epidermal necrolysis: A potential new clinical pattern of drug eruption
Soluble fractions of tumor necrosis factor-alpha, interleukin-6 and of their receptors in toxic epidermal necrolysis: a comparison with second-degree burns.
Drug-induced toxic epidermal necrolysis and pancytopenia: A puzzling association